PMID: 375710Jun 1, 1979Paper

Anticoagulation in myocardial infarction: modern approach to an old problem

The American Journal of Cardiology
W H Frishman, H S Ribner

Abstract

The role of routine anticogulation in acute myocardial infarction continues to be a source of controversy. There is currently strong evidence to suggest that conventional anticoagulation will prevent the formation of most deep vein thrombi and subsequent pulmonary embolization. Anticoagulant agents also appear to reduce the incidence of emboli from cardiac mural thrombi to peripheral arteries. Patients without a predisposition to bleeding are unlikely to have hemorrhagic complications in the hospital after usual doses of anticoagulant drugs. In patients with severe hypertension, prior gastrointestinal bleeding, carcinoma or advanced age, small dose heparin therapy appears to reduce the incidence of venous thrombosis and probably of pulmonary emboli as well. Its value in preventing peripheral arterial embolization has not been defined. Anticoagulation with standard "large" doses is an effective means of preventing the risks of pulmonary and peripheral emboli during the in-patient phase of acute myocardial infarction. Small dose heparin therapy provides an excellent alternative to conventional anticoagulation when there is more than a negligible risk of hemorrhage. There is little evidence at this time to support the use of long-...Continue Reading

References

Jan 15, 1977·Lancet·D P ThomasV V Kakkar
Apr 24, 1976·British Medical Journal·J T RenneyP F Burke
Oct 23, 1976·British Medical Journal·C P Holford
Oct 1, 1976·Circulation·C B MoschosT J Regan
Jun 26, 1975·The New England Journal of Medicine·B ModanM Modan
Jun 26, 1975·The New England Journal of Medicine·J TonasciaH Schmerler
Sep 25, 1971·Lancet·V V KakkarP T Flute
Dec 25, 1971·Lancet·B J MaurerJ P Shillingford
Jun 1, 1973·British Heart Journal·A V SimmonsA F Cox
Sep 20, 1969·Lancet·D Negus, D J Pinto
Oct 17, 1970·Lancet·T S MurrayT D Lawrie
Apr 1, 1972·Circulation·R V Ebert
May 20, 1972·British Medical Journal·A J HandleyP R Fleming
Apr 19, 1973·The New England Journal of Medicine·R WrayJ Shillingford
Mar 29, 1969·British Medical Journal·V V KakkarP T Flute
Apr 18, 1970·British Medical Journal·J M LambieN A Matheson
Apr 18, 1970·British Medical Journal·J M LambieN A Matheson
Feb 20, 1971·British Medical Journal·A N NicolaidesM B Clarke
Mar 16, 1967·The New England Journal of Medicine·D Deykin

❮ Previous
Next ❯

Citations

Jul 1, 1992·Journal of Clinical Pharmacology·M D Freedman
Mar 29, 1984·The New England Journal of Medicine·W H FrishmanW T Friedewald
May 3, 1984·The New England Journal of Medicine
Jan 1, 1981·Acta Medica Scandinavica. Supplementum·E A Loeliger

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.